The mechanisms underlying vascular complications in vEDS are closely linked to mutations in the COL3A1 gene, which encodes type III collagen, a critical structural component of the arterial wall [40]. This evidence concerns the gene COL3A1 and Ehlers-Danlos syndrome, vascular type.